Introduction
============

Helicobacter *pylori* (H. *pylori*) is a Gram-negative, microaerophilic bacterium which selectively colonizes in the human stomach mucosa. The prevalence of H. *pylori* infection is about 50% of the world's population and gastric cancer related to H. *pylori* infection is the fourth most common cancer and the second leading cause of cancer-related death worldwide ([@ref-1]). In general, the prevalence in less developed or developing countries is higher than that in developed countries ([@ref-12]). The infection rates are reported varying from 15.5% to 93.6% in developed and developing countries, respectively ([@ref-11]; [@ref-19]; [@ref-31]).

It is now accepted that H. *pylori* infection is acquired in childhood ([@ref-26]), and H. *pylori* generally persists for the life of the host in the absence of antibiotic therapy ([@ref-22]). The incidence and prevalence rates of childhood infection with H. *pylori* also vary greatly worldwide. Within developed nations, prevalence rates of H. *pylori* infection among children have been shown to range from 6.5% to 65% ([@ref-25]; [@ref-31]). Now in European and North America, the epidemiology of H. *pylori* infection in children has changed in recent decades with low incidence rates, which resulting in prevalence lower than 10% in children and adolescents ([@ref-15]). However, there were few reports in developing counties. There has been a decrease in the H. *pylori* infection rate in the general Chinese population in recent years but it also remained high in some areas among both children and adults after fifteen years ([@ref-7]; [@ref-34]).

China is regarded as one of the largest developing country inhabited by more than one-fifth of the world's population although there has been rapid growth in economy in the past decade. The very limited data showed that the prevalence rate of H. *pylori* infection in Chinese children ranged from 6.8% in three cities of China to 72.3% in northwest China with large regional variations ([@ref-7]; [@ref-35]). Hangzhou, the capital city of Zhejiang Province, which had made quick improvements in industrialization and socioeconomic conditions since the 1980s, is a representative city of eastern China. But few studies have assessed the prevalence of H. *pylori* infection in this area. The lack of these data in our pediatric population has hampered the better understanding of the disease burden in our society and the healthcare planning for resources allocation to tackle H. *pylori*-associated diseases which are usually encountered in adulthood. The aim of this study was to estimate the prevalence of H. *pylori* infection among children in Hangzhou, China from 2007 to 2014 and evaluate the characteristics of H. *pylori* infection in children.

Methods
=======

Study population
----------------

Subjects aged from three to 18 years old who were referred for the detection of H. *pylori* infection using ^13^C-urea breath test (^13^C-UBT) were recruited at the Children's hospital, Zhejiang University School of Medicine from January 1, 2007 to December 31, 2014. The main symptoms of every subject, besides a history of H. *pylori* infected family member were recorded, including abdominal pain, anorexia, nausea/vomiting, abdominal distension, hiccup, constipation, halitosis, diarrhea and failure to thrive/weight loss. All children should have been fasting more than 6 h, and had not used bismuth salts, proton-pump inhibitors (PPIs), or any antibiotics (amoxicillin, tetracycline, metronidazole, clarithromycin, azithromycin, or other) within one month before the ^13^C-UBT ([@ref-16]). The major exclusion criteria included: age younger than three or older than 18, children with incomplete patient data, patients who previously diagnosed as H. *pylori* infection and received treatment for H. *pylori* infection even with drug withdrawal 4 weeks prior to the ^13^C-UBT.

Detection of H. *pylori* infection
----------------------------------

H. *pylori* infection was established by the ^13^C-UBT kit, Helikit (Isodiagnostika Inc., Edmonton, AB, Canada) according to standard protocols. Briefly, after a minimum fasting period of 6 h, a baseline exhaled breath sample was obtained using a collection bag. The children then drank 75 ml of a citrus-flavoured liquid preparation (75 mg of ^13^C-labelled urea). Thirty minutes later, another breath exhaled sample was stored in collection bag. Breath samples were stored at room temperature and then analyzed by an isotope selective nondispersive infrared spectrometer, namely by ISOMAX 2000 (Isodiagnostika Inc., Edmonton, AB, Canada). The test was defined as positive when delta over baseline (DOB) value calculated after thirty minutes was 3.5 *δ*‰ or more ([@ref-18]).

Statistics
----------

Descriptive statistics such as median and interquartile range of age, percentages were calculated for demographic data and results were analyzed by chi-squaretest. The distribution of H. *pylori* infection rate by year was analyzed by Linear-by-Linear association. Multivariate logistic regression analysis was used to control for the potential confounding variables associated with H. *pylori* infection. Results of logistic regression were expressed as odds ratios (OR) with 95% confidence intervals (CI). Statistical analysis was performed using SPSS version 19.0 (SPSS Inc, USA) and *P* value was calculated. Two tailed *P* \< 0.05 was considered statistically significant.

Ethical considerations
----------------------

The study was approved by Institutional Review Board and Institutional Ethics Committees of the Children's hospital, Zhejiang University School of Medicine (2016-IRBAL-078).

Results
=======

Demographic data
----------------

A total of 12,796 subjects were enrolled in this study and there were 6,880 boys and 5,916 girls, yielding a male-to-female ratio of 1.16:1. All children were divided into three age groups, including 3--6 (pre-school age), 7--11 (school age) and 12--17 (adolescent) years age group. The gender distribution was consistent in different age groups. The median and interquartile range of age of all children were 7.50 (5.75--10.08) years, while boys were 7.50 (5.67--10.08) years and girls were 7.58 (5.83--10.08) years.

H. *pylori* infection rate
--------------------------

Overall, 18.6% (2,382/12,796) children were H. *pylori* positive according to the DOB value of 13C-UBT ([Table 1](#table-1){ref-type="table"}). The annual positive rates decreased from 2007 to 2014 (*χ*^2^ = 20.461, *p* \< 0.01) ([Fig. 1](#fig-1){ref-type="fig"}). And the infection rate decreased in the latest four-year period 2011--2014, compared to the former four-year period 2007--2010 (*χ*^2^ = 25.798, *p* \< 0.01) ([Fig. 2](#fig-2){ref-type="fig"}). The positive rates of H. *pylori* was 14.8% (800/5,408) in 3--6 years age group, 20.2% (1,179/5,829) in 7--11 years age group, and 25.8% (403/1,559) in 12--17 years age group, which increased with age and were statistically significant (*χ*^2^ = 116.002, *p* \< 0.001) ([Table 1](#table-1){ref-type="table"}). Furthermore, the positive rates were higher in boys (19.9%, 1,366/6,880) than girls (17.2%, 1,016/5,916), and the difference was also statistically significant (*χ*^2^ = 15.090, *p* \< 0.001) ([Table 1](#table-1){ref-type="table"}).
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###### Demographic characteristics of the 12,796 subjects.

![](peerj-05-2937-g003)

                                                      H. *pylori*-positive   H. *pylori*-negative   Total    *P* value
  --------------------------------------------------- ---------------------- ---------------------- -------- -----------
  **Age groups (years)**                                                                                     
  3--6                                                800 (14.8)             4,608 (85.2)           5,408    \<0.001
  7--11                                               1,179 (20.2)           4,650 (79.8)           5,829    
  12--17                                              403 (25.8)             1,156 (74.2)           1,559    
  **Gender**                                                                                                 
  Female                                              1,016 (17.2)           4,900 (82.8)           5,916    \<0.001
  Male                                                1,366 (19.9)           5,514 (80.1)           6,880    
  **Gastrointestinal symptoms**                                                                              
  No                                                  432 (17.5)             2,034 (82.5)           2,466    0.119
  Yes                                                 1,950 (18.9)           8,380 (81.1)           10,330   
  **History of H. *pylori* infected family member**                                                          
  No                                                  2,139 (18.4)           9,488 (81.6)           11,627   0.045
  Yes                                                 243 (20.8)             926 (79.2)             1,169    
  **Total**                                           2,382 (18.6)           10,414 (81.4)          12,796   --

**Notes.**

Data expressed as number (%).

![The distribution of H. *pylori* infection rate by year from 2007 to 2014.\
The bars represent the number of enrolled subjects each year. H. *pylori* negative and positive subjects are white and black respectively. The line chart represent the positive rates of H. *pylori* infection each year.](peerj-05-2937-g001){#fig-1}

![The H. *pylori* infection rates between two four-year period, 2007--2010 and 2011--2014.\
The percentages on top of the bars represent the total H. *pylori* infection rates in four-year periods. \*\**p* \< 0.01.](peerj-05-2937-g002){#fig-2}

The main gastrointestinal symptoms of children undergoing ^13^C-UBT are abdominal pain, anorexia, nausea/vomiting, abdominal distension, hiccup, constipation, halitosis, diarrhea and failure to thrive/weight loss. There were 80.7% children (10,330/12,796) with at least one gastrointestinal symptom in the prior months. The positive rate of H. *pylori* infection in children with these symptoms was 18.9% (1,950/10,330), demonstrating no significant difference compared to 19.3% (2,466/12,796) children without gastrointestinal symptoms (17.5%, 432/2,466) (*χ*^2^ = 2.426, *p* = 0.119) ([Table 1](#table-1){ref-type="table"}).

There were 1,169 children had a history of H. *pylori* infected family member, and the H. *pylori* infection rate was higher than those without a familial history (20.8% versus 18.4%, *χ*^2^ = 4.005, *p* \< 0.05) ([Table 1](#table-1){ref-type="table"}).

Possible risk factors associated with H. *pylori* infection
-----------------------------------------------------------

[Table 2](#table-2){ref-type="table"} shows the results from the multivariate logistic regression performed to assess risk factors for H. *pylori* infection. Age, gender, gastrointestinal symptoms and history of H. *pylori* infected family member were found together to be significantly associated with H. *pylori* infection (all *p* \< 0.05). Specifically, children in 7--11 years age group and in 12--17 years age group were 1.474 and 2.031 times as likely to be H. *pylori* infected as children in 3--6 years age group (95% CI \[1.335--1.627\] and 95% CI \[1.772--2.328\] respectively, all *p* \< 0.001). Boys were 1.209 times as likely to be H. *pylori* infected as girls (95% CI \[1.104--1.323\], *p* \< 0.001) and children with a history of H. *pylori* infected family member were 1.289 times compared to those without the familial history. Furthermore, gastrointestinal symptom was also one of risk factors for H. *pylori* infection, as it was 1.141 times in children with gastrointestinal symptoms compared to children without them (95% CI \[1.009--1.289\], *p* \< 0.05).
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###### Logistic regression analysis for possible risk factors associated with H. *pylori* infection.
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  Variables                                           OR (95%CI)             *P* value
  --------------------------------------------------- ---------------------- -----------
  **Age groups (years)**                                                     
  3--6                                                --                     
  7--11                                               1.474 (1.335--1.627)   \<0.001
  12--17                                              2.031 (1.772--2.328)   \<0.001
  **Gender**                                                                 
  Female                                              --                     
  Male                                                1.209 (1.104--1.323)   \<0.001
  **Gastrointestinal symptoms**                                              
  No                                                  --                     
  Yes                                                 1.141 (1.009--1.289)   0.035
  **History of H. *pylori* infected family member**                          
  No                                                  --                     
  Yes                                                 1.289 (1.100--1.511)   0.002

**Notes.**

ORodds ratioCIconfidence interval

Discussions
===========

The present study assessed the ^13^C-UBT in the pre-treatment phase to evaluate current H. *pylori* infection in children with gastrointestinal symptoms. The prevalence was higher than in developed countries but lower than in some developing countries ([@ref-31]). It was higher than it reported in three cities (Beijing, Guangzhou and Chengdu) of mainland China, Hong Kong and Taiwan among asymptomatic children or school children, but lower than most of mainland China ([Table 3](#table-3){ref-type="table"}). These could be due to cohort selection, detection method and the geographic area difference which may also reflect the personal and environmental hygiene. Subjects in our study enrolled from patients most of that had gastrointestinal symptoms and were suggested to detect the H. *pylori* infection, so the incidence rate would be more or less higher than asymptomatic or general population. Currently, there are many diagnostic tools to detect H. *pylori* infection, with non-invasive methods being considered as the most desirable for use especially in children. The ^13^C-UBT has been reported to have excellent sensitivity and specificity for the noninvasive identification of H. *pylori* infection in children and it is recommended for situations when endoscopy is not available or necessary ([@ref-13]; [@ref-24]). ^13^C-UBT has superiority over serologic methods by its high reliability and the ability to differentiate present from past infection ([@ref-2]). The geographic distribution of H. *pylori* infection is correlated with the geographic distribution of gastric cancer. Muping County in Shandong Province, Wuwei County in Gansu Province and Jiangsu Province are all the area with high risk of gastric cancer ([@ref-27]; [@ref-34]; [@ref-35]). That may be associated with the high prevalence of H. *pylori* infection in this area.
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###### Comparison of prevalence of H. *pylori* infection among children in China.
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  Authors     Recruitment                 Area        Year         Age (year)   Method         No.     Prevalence (%)
  ----------- --------------------------- ----------- ------------ ------------ -------------- ------- ----------------
  [@ref-7]    Asymptomatic children       Beijing     2009--2011   Newborn      HpSA           330     0.6
                                          Guangzhou                1--12m                      319     2.5
                                          Chengdu                  1--3                        289     2.1
                                                                   4--6                        624     7.2
                                                                   7--9                        528     6.1
                                                                   10--12                      308     11.0
                                                                   13--15                      685     8.0
                                                                   16--18                      408     13.5
  [@ref-29]   School children             Hong Kong   2007         6--8         UBT            300     9.3
                                                                   9--10                       301     11.0
                                                                   11--12                      472     14.8
                                                                   13--14                      779     13.0
                                                                   15--16                      289     12.5
                                                                   17--19                      339     16.5
  [@ref-17]   School children             Taiwan      2004         9--12        Serology       1,625   11.0
                                                                   13--15                      325     12.3
  [@ref-34]   School children             Muping,     2006         8--9         HpSA           122     26.2
                                          Shandong                 10--11                      125     40.0
                                                                   12--13                      142     41.6
                                                                   14--15                      131     42.0
                                          Yanqing,    2006         8--9         HpSA           130     15.4
                                          Beijing                  10--11                      136     27.9
                                                                   12--13                      125     29.6
                                                                   14--15                      125     29.6
  [@ref-3]    Population-based cohort     Guangzhou   2003         3--5         Serology       180     19.4
                                          Guangdong                5--10                       105     22.9
                                                                   10--20                      185     36.8
  [@ref-4]    Population-based cohort     Beijing     2003         2--10        UBT            19      57.8
                                                                   11--20                      52      46.2
  [@ref-27]   Population-based cohort     Jiangsu     2004--2005   \<20         UBT/Serology   48      60.4
  [@ref-35]   Population-based cohort     Wuwei,      2007--2008   3--5         HpSA           99      68.7
                                          Gansu                    6--9                        240     70.4
                                                                   10--14                      440     73.0
                                                                   15--18                      159     75.5
  [@ref-33]   Gastrointestinal symptoms   Dongguan,   2010--2011   3--7         Histology/     119     39.5
                                          Guangdong                8--12        RUT/           134     41.0
                                                                   13--16       UBT            123     54.5
  [@ref-32]   Gastrointestinal symptoms   Zunyi       2000--2006   10--20       UBT            2,645   40.0
  Our study   Gastrointestinal symptoms   Hangzhou,   2007--2014   3--6         UBT            5,408   14.8
                                          Zhejiang                 7--11                       5,829   20.2
                                                                   12--17                      1,559   25.8

**Notes.**

HpSAH. *pylori* stool antigen testUBTurea breath testRUTrapid urease testmmonths

Although there is apparent variation in the prevalence of H. *pylori* infection between developing and developed countries in children, it is reported all around the world that the prevalence was associated with age ([@ref-30]; [@ref-34]). In our study, the prevalence of H. *pylori* infection was also shown to increase with age. Pre-school age children had a lower significant prevalence than school age and adolescent. The increase in H. *pylori* prevalence with age is thought to represent the improvements in socioeconomic conditions and sanitary standards through the generations. In Russia, the prevalence of H. *pylori* infection reduced markedly within a 10-year period (from 1995 to 2005) due to the improvements in standards of living ([@ref-30]). With the development of economic growth in China within decades, the environmental and hygienic conditions were dramatically improved, due to which the prevalence of H. *pylori* infection is decreasing in China ([@ref-20]). In consistent with it, the annual positive rates decreased during eight-year period (from 2007 to 2014) in our study ([Fig. 1](#fig-1){ref-type="fig"}). The age-dependent manner of H. *pylori* positive rate in children may also reflect the inverse relation to the socioeconomic status, sanitation and living conditions in China ([@ref-34]). The increase of prevalence might be the effect of accumulation because that the acquisition rates were higher than the loss rates ([@ref-21]). With the growing of age, expanding range of activity, collective living and meal in high school lead to the increase of exposure to H. *pylori* infection and opportunities to cross infection ([@ref-33]). But it needs to be further investigated.

It was reported that the male predominance of H. *pylori* infection in adults was a global and homogeneous phenomenon, but such predominance was not apparent in children ([@ref-6]; [@ref-30]). But our data showed a higher prevalence in boys than girls and in different years age group ([Table 2](#table-2){ref-type="table"}). It is consistent with the study in Brazil that male gender was one of the risk factors for the acquisition and maintenance of the H. *pylori* infection ([@ref-23]). The prevalence of H. *pylori* infection in a community is related to three factors: the incidence rate of infection, the rate of infection loss (either spontaneous eradication or curative treatment) and the relative survival of those with and without infection. Differential incidence, differential antibiotic exposure or differential protective immunity between genders, which lead to greater loss of infection (or seroreversion) in girls or adults women than in men, may explain the different results observed between children and adult studies ([@ref-6]). On the other hand,it may be explained that boys are naturally more active and have poor personal hygiene than girls as the prevalence of H. *pylori* infection is inversely related to sanitation condition. But the role of gender as a risk factor for H. *pylori* infection is still debated.

Abdominal complaints such as pain, anorexia, nausea/vomiting, or other dyspeptic symptoms are nonspecific and can be caused by different organic disease within and outside the digestive tract. The European Pediatric Task Force concluded in their guidelines on management of H. *pylori* infection that, in children, H. *pylori* infection is not related to gastrointestinal symptoms ([@ref-9]). Studies comparing the prevalence among symptomatic and asymptomatic children show different results on the relationship between gastrointestinal symptoms and the prevalence of H. *pylori* infection ([@ref-5]; [@ref-8]). A meta-analysis reported recently that children with upper abdominal pain or epigastric pain were at two- to three fold higher risk for H. *pylori* infection than children without these symptoms but it could not been confirmed in children seen in primary care ([@ref-28]). According to multivariate logistic regression analysis, our study showed that gastrointestinal symptom and a history of H. *pylori* infected family member were also the significant risk factors for H. *pylori* infection. Similarly, other studies showed that upper GIT symptoms (RAP, anorexia, nausea), family history of peptic disease, and nausea/vomiting were significantly associated with H. *pylori* infection ([@ref-8]; [@ref-14]). However, there are many other possible risk factors associated with H. *pylori* infection identified in most of the published studies, including socioeconomic indicators, family income, household crowding, number of children sharing the same room, parents' education and sharing a bed with children ([@ref-10]). Our results were limited because of cohort selection and the lack of data in these matters, and the determinants of H. *pylori* infection should be investigated by further studies.

In conclusion, the strength of our study was that it evaluated a large number of children in a long period in Hangzhou, a representative city of eastern China. The prevalence of H. *pylori* infection using ^13^C-UBT increased with age in children and boys were apt to be H. *pylori* positive compared with girls. The founding suggests that primary infection in childhood is usual and the effect of accumulation might be responsible for the increase of prevalence with age. Besides age and male predominance, gastrointestinal symptom and a history of H. *pylori* infected family member were also the possible risk factors for H. *pylori* infection. In children with history of H. *pylori* infected family member, testing for H. *pylori* may be considered especially when they are symptomatic. These observations could substantially change H. *pylori* management strategies in children in China.

Supplemental Information
========================

10.7717/peerj.2937/supp-1

###### Raw data

###### 

Click here for additional data file.

We sincerely thank the children and their parents for providing the information to take part in this study. We also thank Lejing Yang and Qian Shu for typewriting the data and thank Kewen Jiang, Weifen Zhu and Xi Chen for suggestions on article editing.

Additional Information and Declarations
=======================================

The authors declare there are no competing interests.

[Xiaoli Shu](#author-1){ref-type="contrib"} performed the experiments, analyzed the data, wrote the paper, prepared figures and/or tables.

[Mingfang Ping](#author-2){ref-type="contrib"} and [Guofeng Yin](#author-3){ref-type="contrib"} contributed reagents/materials/analysis tools.

[Mizu Jiang](#author-4){ref-type="contrib"} conceived and designed the experiments, reviewed drafts of the paper.

The following information was supplied relating to ethical approvals (i.e., approving body and any reference numbers):

The study was approved by the parents and the ethics committees of the Children's hospital, Zhejiang University School of Medicine (2016-IRBAL-078).

The following information was supplied regarding data availability:

The raw data has been supplied as a [Supplemental File](#supplemental-information){ref-type="supplementary-material"}.
